Effects of topical and systemic administration of Eugenia caryophyllata buds essential oil on corneal anesthesia and analgesia

Emad Khalilzadeh, Reza Hazrati, Gholamreza Vafaei Saiah


Clinical studies suggest that essential oil of Eugenia caryophyllata (Clove) buds (EOEC) is efficacious in the treatment of dental pain. In the present study, we investigated the analgesic and local anesthetic effects of EOEC and its possible mechanisms of action in acute corneal pain in rats. EOEC was extracted by hydro-distillation in a Clevenger type apparatus from clove buds. The acute corneal pain was induced by applying a drop (40 µl) of 5 M NaCl solution on the corneal surface, and the numbers of eye wipes were counted during the first 30 s. The mechanical sensation of the cornea was evaluated by calibrated Von Frey filaments. Systemic administration of EOEC (100 and 200 mg/kg, SC) and morphine (2.5 and 5 mg/kg, IP) produced a significant antinociceptive effect in acute corneal pain. Pretreatment with naloxone or atropine prevented the EOEC-induced analgesia. However, L-arginine and methylene blue did not change the suppressive effect of EOEC on corneal pain response. Topical application of EOEC, eugenol and lidocaine significantly decreased corneal sensitivity. Combination treatments of eugenol (25 µg) with lidocaine (0.5%) and EOEC (50 µg) with lidocaine (0.5%) also significantly suppressed corneal sensitivity. Systemic administration of EOEC produced analgesia in the acute corneal pain through mechanisms that involved both opioidergic and cholinergic systems. In addition, topical instillation of EOEC, eugenol, and lidocaine produced local anesthesia in the rat cornea. Sub-anesthetic doses of EOEC or eugenol produced a significant local anesthetic effect when concurrently used with the sub-anesthetic dose of lidocaine.


Eugenia caryophyllata; Analgesic; Corneal pain; Lidocaine; Local anesthesia; Eugenol.

Full Text:



Arung ET, Matsubara E, Kusuma IW, Sukaton E, Shimizu K, Kondo R. Inhibitory components from the buds of clove (Syzygium aromaticum) on melanin formation in B16 melanoma cells. Fitoterapia. 2011;82:198-202.

Soto CG, Burhanuddin CG. Clove oil as a fish anaesthetic for measuring length and weight of rabbit fish (Siganus lineatus). Aquaculture. 1995;136:149-152.

Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Mahmoud R, Mahdouani K, et al. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007;21:501-506.

Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol. 2009;58:1454-1462.

Corrêa MFP, Melo GO, Costa SS. Substâncias de origem vegetal potencialmente úteis na terapia da Asma. Rev Bras Farmacogn. 2008;18:785-797.

Gülçin I, Elmastas M, Aboul-Enein HY. Antioxidant activity of clove oil - A powerful antioxidant source. Arabian J Chem. 2012;5:489-499.

Kildeaa MA, Allanb GL, Kearney RE. Accumulation and clearance of the anaesthetics clove oil and AQUI-S from the edible tissue of silver perch (Bidyanus bidyanus). Aquaculture. 2004;232:265-277.

Park SH, Sim YB, Lee JK, Kim SM, Kang YJ, Jung JS, et al. The analgesic effects and mechanisms of orally administered eugenol. Arch Pharm Res. 2011;34:501-507.

Lionnet L, Beaudry F, Vachon P. Intrathecal eugenol administration alleviates neuropathic pain in male Sprague-Dawley rats. Phytother Res. 2010;24:1645-1653.

Daniel AN, Sartoretto SM, Schmidt G, Caparroz-Assef SM, Bersani-Amado CA, Cuman RKN. Anti- inflammatory and antinociceptive activities A of eugenol essential oil in experimental animal models. Rev Bras Farmacogn. 2009;19:212-217.

Kurian R, Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. Effect of eugenol on animal models of nociception. Indian J of Pharmacol. 2006;38: 341-345.

Okhubo T, Shibata M. The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol. J Dent Res. 1997;76:848-851.

Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: is it real? Ocul Surf. 2009;7:28-40.

Belmonte C, Acosta MC, Gallar J. Neural basis of sensation in intact and injured corneas. Exp Eye Res 2004;78:513-525.

Miranda HF, Sierralta F, Prieto JC. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol Biochem Behav. 2009;92:314-318.

Zdunić G, Godevac D, Milenković M, Vucićević D, Savikin K, Menković N, et al. Evaluation of Hypericum perforatum oil extracts for an antiinflammatory and gastroprotective activity in rats. Phytother Res. 2009;23:1559-1564.

Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109-110.

Khalilzadeh E, Hazrati R, Vafaei Sayah Gh. Evaluation of chemical composition, anti-inflammatory and anti-nociceptive effects of Eugenia caryophyllata buds essential oil. J Herbal Drugs. 2014;5:68-76.

Farazifard R, Safapour F, Sheibani V, Javan M. Eyewiping test: a sensitive animal model for acute trigeminal pain studies. Brain Res Brain Res Protoc. 2005;16:44-49.

Khalilzadeh E, Hazrati R, Vafaie Sayah G, Hasannejad H. Opioidergic and cholinergic but not nitric oxide pathways are involved in antinociceptive activity of Vitex agnus-castus essential oil in the acute trigeminal model of pain in rat. Asian J Pharm Clin Res. 2015;8:283-286.

Ren KE. An improved method for assessing mechanical allodynia in therat. Physiol Behav. 1999;67:711-716.

Kim J, Kim NS, Lee KC, Lee HB, Kim MS, Kim HS. Effect of topical anesthesia on evaluation of corneal sensitivity and intraocular pressure in rats and dogs. Vet Ophthalmol. 2013;16:43-46.

Zagon IS, Sassani GW, Immonen JA, McLaughlin PJ. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone. Clin Experiment Ophthalmol. 2014;42:159-168.

Bates B, Mitchell K, Keller JM, Chan C, Swaim WD, Yaskovich R, et al. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain. 2010;149:522-528.

Carstens E, Kuenzier N, Handwerker HO. Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to the oral and ocular mucosa. J Neurophysiol. 1998;80:465-492.

Hirata H, Meng ID. Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease. Invest Ophthalmol Vis Sci. 2010;5:3969-3976.

Pan Z, Wang Z, Yang H, Zhang F and Reinach PS. TRPV1 activation is required for hypertonicity stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2011;52:485-493.

Tamaddonfard E, Khalilzadeh E, Hamzeh-Gooshchi N, Seiednejhad-Yamchi S. Central effect of histamine in a rat model of acute trigeminal pain. Pharmacol Rep. 2008;60:219-224.

Dalai MK, Bhadra S, Chaudhary SK, Bandyopadhyay A, Mukherjee PK. Anti-cholinesterase activity of the standardized extract of Syzygium aromaticum L. Pharmacogn Mag. 2014;10:S276-S282.

Dohi S, Terasaki M, Makino M. Acetylcholinesterase inhibitory activity and chemical composition of commercial essential oils. J Agric Food Chem. 2009;57:4313-4318.

Cozanitis DA, Friedmann T, Furst S. Study of the analgesic effects of galanthamine, a cholinesterase inhibitor. Arch Int Pharmacodyn Ther. 1983;266:229-238.

Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg. 1997;85:847-853.

Park CK, Kim K, Jung SJ, Kim MJ, Ahn DK, Hong SD, et al. Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system. Pain. 2009;144:84-94.

Hashimoto S, Uchiyama K, Maeda M, Ishitsuka K, Furumoto K, Nakamura Y. In vivo and in vitro effects of zinc oxide-eugenol (ZOE) on biosynthesis of cyclo-oxygenaseproducts in rat dental pulp. J Dent Res. 1988;67:1092-1096.

Park CK, Li HY, Yeon KY, Jung SJ, Choi SY, Lee S, et al. Eugenol inhibits sodium currents in dental afferent neurons. J Dent Res. 2006;85:900-904.

Lee MH, Yeon K-Y, Park C-K, Li HY, Fang Z, Kim MS, et al. Eugenol inhibits calcium currents in dental afferent neurons. J Dent Res. 2005;84:848-851.

Yang BH, Piao ZG, Kim YB, Lee CH, Lee JK, Park K, et al. Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res. 2003;82:781-785.

Chung G, Im ST, Kim YH, Jung SJ, Rhyu MR, Oh SB. Activation of transient receptor potential ankyrin 1 by eugenol. Neuroscience. 2014;261:153-160.

Leffler A, Fischer MJ, Rehner D, Kienel S, Kistner K, Sauer SK, et al. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest. 2008;118:763-776.

Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, et al. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA. 2008;105:9099-9104.

Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev. 2009;60:255-266.

Ghelardini C, Galeotti N, Mannelli LDC, Mazzanti G, Bartolini A. Local anaesthetic activity of β-caryophyllene. Il Farmaco 2001;56:387-389.

Fernandes ES, Passos GF, Medeiros R, Cunha FMD, Ferreira J, Campos MM, et al. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur J Pharmacol. 2007;569: 228-236.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.